Specific cancer rates may differ in patients with hereditary haemorrhagic telangiectasia compared to controls. - Test2 - elhamkhani - TriplyDB

Specific cancer rates may differ in patients with hereditary haemorrhagic telangiectasia compared to controls.

Specific cancer rates may differ in patients with hereditary haemorrhagic telangiectasia compared to controls.

http://www.wikidata.org/entity/Q37479646

about

Optimal management of hereditary hemorrhagic telangiectasia.Pulmonary arteriovenous malformations.Can Iron Treatments Aggravate Epistaxis in Some Patients With Hereditary Hemorrhagic Telangiectasia?20-year follow-up study of Danish HHT patients-survival and causes of death How to manage patients with hereditary haemorrhagic telangiectasia.Endoglin-based biological therapy in the treatment of angiogenesis-dependent pathologies.Cancer and hereditary haemorrhagic telangiectasia.The Lung in Hereditary Hemorrhagic Telangiectasia.

P2860

Q34388065-6F46524C-35DA-4253-AA16-6233C50F6C13 Q35044725-16EA9F73-51B3-485F-B453-C971D47B6D33 Q37394098-B4033E57-756A-48BC-B636-F465CA1076F4 Q37431600-77F68A3F-98E2-430A-BD81-907C55937BD4 Q38552986-616B57F5-CF89-4ECB-B17E-51D0867D0E6E Q39401943-A15E0478-779C-4E18-8E41-8FBF74EE3196 Q46597333-65FE49B1-A6EC-418C-9F3A-44D54D2B4E69 Q47789592-864D81BB-D84E-4ADA-8C11-39DEFF6C014B

P2860

Specific cancer rates may differ in patients with hereditary haemorrhagic telangiectasia compared to controls.

http://www.wikidata.org/entity/Q37479646

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Specific cancer rates may diff ...... iectasia compared to controls.

@en

Specific cancer rates may diff ...... iectasia compared to controls.

@nl

type

label

Specific cancer rates may diff ...... iectasia compared to controls.

@en

Specific cancer rates may diff ...... iectasia compared to controls.

@nl

prefLabel

Specific cancer rates may diff ...... iectasia compared to controls.

@en

Specific cancer rates may diff ...... iectasia compared to controls.

@nl

P1433

Q37479646-C8484DE7-F5ED-4B29-A2AD-30634CA37194

P1476

Q37479646-0A3FFB8B-46A9-4B55-B134-FF8A28F2C822

P2093

Q37479646-A57E3E10-A97D-472B-9995-4A4B0F63B3E8

Q37479646-D5108BC0-E5F7-4152-9580-891FFFEAD21C

P2860

Q37479646-00867D22-B6E4-499C-9988-FBC7A90A1792

Q37479646-08902DA6-6D1A-443E-B6AD-48D216355C06

Q37479646-097E5DF0-C0BE-4EA4-805A-30AC993074AA

Q37479646-0B798D36-99D8-420C-8F3B-FCF914BECA25

Q37479646-152ADC54-B856-469D-B26E-690FEA536FC0

Q37479646-1B83A68A-B8B4-40A8-B126-8D7DF9310745

Q37479646-1D9C2696-6CC3-4F7E-BBD5-2788D85F72D8

Q37479646-1DC65D1F-2745-4FE8-B1A3-D0D1CC3D0768

Q37479646-2EAF9E5E-7DCC-44B0-B5C2-60E0175C6921

Q37479646-3068C426-18B1-4B5D-AD84-5B4A87DDD939

P2888

Q37479646-37292308-0342-4924-B949-3323FBE8D7D8

P304

Q37479646-29D7681A-B37F-4DA6-9504-9B1BAA0F84F9

P31

Q37479646-DD184770-B25E-4A67-A2A9-6284F35894D9

P356

Q37479646-2C2B54FB-B44D-4CF2-B483-1E260C1B41DA

P478

Q37479646-576460A2-F0B2-42B3-A877-FCE332770F38

P50

Q37479646-07502D35-1099-4908-887C-5578A17260A1

Q37479646-0CCABE4C-E953-4E6F-9D4A-B5FE453EA99D

P577

Q37479646-BF38715F-4679-46B9-8EEA-E4D74B72CDD7

P5875

Q37479646-C73DD54A-20AA-4726-AD76-6EDA95125BA8

P6179

Q37479646-E9AEA13F-036B-4701-A780-8BE003A7F620

P698

Q37479646-903BFAA3-711C-4109-AB93-A02C68557611

P932

Q37479646-6B05CECD-3725-45CA-9881-AC6417B83FE2

P356

1750-1172-8-195

P1433

Orphanet Journal of Rare Diseases

P1476

Specific cancer rates may diff ...... iectasia compared to controls.

@en

P2093

B Maneesha Silva

http://www.w3.org/2001/XMLSchema#string

Hannah L Devlin

http://www.w3.org/2001/XMLSchema#string

P2860

Hereditary haemorrhagic telangiectasia: a clinical and scientific review

Radiation dose to the brain and subsequent risk of developing brain tumors in pediatric patients undergoing interventional neuroradiology procedures.

Should asymptomatic patients with hereditary haemorrhagic telangiectasia (HHT) be screened for cerebral vascular malformations? Data from 22,061 years of HHT patient life

Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome).

International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia.

Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment.

ALK1-Fc inhibits multiple mediators of angiogenesis and suppresses tumor growth.

Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries.

Lifestyle and dietary influences on nosebleed severity in hereditary hemorrhagic telangiectasia.

Directional next-generation RNA sequencing and examination of premature termination codon mutations in endoglin/hereditary haemorrhagic telangiectasia

P2888

1750-1172-8-195

P304

195

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1750-1172-8-195

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Claire L Shovlin

P577

2013-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259392899

http://www.w3.org/2001/XMLSchema#string

P6179

1043466972

http://www.w3.org/2001/XMLSchema#string

P698

24354965

http://www.w3.org/2001/XMLSchema#string

P932

3891994

http://www.w3.org/2001/XMLSchema#string